Santhera Pharmaceuticals Holding AG

Swiss Stock Exchange:SANN.SW

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Switzerland

Market Cap

USD 239.69 M

Share Price

USD 18.63

Avg Daily Volume

29,393

Change (1 day)

0.29%

Change (1 year)

78.10%

Change (YTD)

21.90%

Santhera Pharmaceuticals Holding AG EBT Margin for the year ending December 31, 2024: -106.51%

Santhera Pharmaceuticals Holding AG EBT Margin is -106.51% for the year ending December 31, 2024, a -300.92% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Santhera Pharmaceuticals Holding AG EBT Margin for the year ending December 31, 2023 was 53.01%, a -105.61% change year over year.
Santhera Pharmaceuticals Holding AG EBT Margin for the year ending December 31, 2022 was -944.95%.
Santhera Pharmaceuticals Holding AG EBT Margin for the year ending December 31, 2020 was -449.47%, a 1,741.85% change year over year.